{
    "code": "02020040",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020040",
    "time": "2015-08-23 10:51:18",
    "許可證字號": "衛署藥輸字第020040號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/12\/06",
    "註銷理由": "屆期未申請展延",
    "有效日期": "92\/12\/30",
    "發證日期": "82\/08\/09",
    "許可證種類": "製　劑",
    "舊證字號": "02017013",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202004004",
    "中文品名": "亞利洛錠５公絲",
    "英文品名": "ALVERIX TABLETS 5 MG",
    "適應症": "與ＴＨＩＡＺＩＤＥ及其他導至流失鉀離子之利尿劑併用時治療高血壓",
    "劑型": "110錠劑",
    "包裝": "盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "AMILORIDE HCL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1007001100  振利有限公司",
    "申請商地址": "台北巿內湖區行愛路77巷61號7樓",
    "主製造廠": {
        "製造廠名稱": "F100003000  REMEDICA LTD. MANUFACTURERS OF PHARMACEUTICALS",
        "製造廠廠址": "AHARNON STR,INDUSTRIAL ESTATE,P.O.BOX 51706,3508,LIMASSOL,CYPRUS",
        "製造廠公司地址": "",
        "製造廠國別": "CYPRUS",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4028000110",
            "成分名稱": "AMILORIDE HCL",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ]
}